Lee Hyun Gu, Kim Chan Wook, Lee Jong Lyul, Yoon Yong Sik, Park In Ja, Lim Seok-Byung, Yu Chang Sik, Kim Jin Cheon
Division of Colon and Rectal Surgery, Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Int J Colorectal Dis. 2022 May;37(5):989-997. doi: 10.1007/s00384-022-04138-2. Epub 2022 Apr 5.
Abdominoperineal resection (APR) has been considered to have a higher risk of local recurrence and poorer survival outcome than sphincter-saving operation (SSO) in patients with rectal cancer. This study compared long-term oncologic outcomes and prognostic parameters in propensity score-matched patients who underwent APR and SSO.
This study analyzed 958 consecutive patients with lower rectal cancer who underwent preoperative chemoradiotherapy followed by APR or SSO between 2005 and 2015. Propensity score matching analysis was performed to adjust baseline characteristics, including clinical stage, tumor distance from the anal verge, and tumor size.
In the entire cohort, the APR group had larger and lower tumors and showed significantly shorter 5-year disease-free survival (DFS) than the SSO group (64.5% vs. 75.8%, p = 0.01). After propensity score matching, there were no significant between-group differences in local (9.5% vs. 8.0%, p = 0.59) and systemic (27.9% vs. 23.4%, p = 0.3) recurrence rates, and 5-year DFS (67.5% vs. 69.9%, p = 0.49) and overall survival (80.8% vs. 82.9%, p = 0.65) rates. A lower number of lymph nodes retrieved was independently associated with recurrence and survival outcomes in the APR group, whereas poorly differentiated histology was an independent associated parameter in the SSO group. Advanced stage and perineural invasion were identified as independent prognostic parameters in both groups.
This study indicated that the long-term oncologic outcomes of APR were comparable to those of SSO. Because prognostic parameters associated with oncologic outcomes differed between the respective procedures, correctable parameters could be ameliorated through complete total mesorectal excision and personalized systemic treatment.
在直肠癌患者中,腹会阴联合切除术(APR)被认为比保留括约肌手术(SSO)具有更高的局部复发风险和更差的生存结果。本研究比较了倾向评分匹配的接受APR和SSO的患者的长期肿瘤学结局和预后参数。
本研究分析了958例连续的低位直肠癌患者,这些患者在2005年至2015年间接受了术前放化疗,随后接受了APR或SSO。进行倾向评分匹配分析以调整基线特征,包括临床分期、肿瘤距肛缘距离和肿瘤大小。
在整个队列中,APR组的肿瘤更大且更低,5年无病生存率(DFS)显著短于SSO组(64.5%对75.8%,p = 0.01)。倾向评分匹配后,局部(9.5%对8.0%,p = 0.59)和全身(27.9%对23.4%,p = 0.3)复发率、5年DFS(67.5%对69.9%,p = 0.49)和总生存率(80.8%对82.9%,p = 0.65)在组间无显著差异。APR组中获取的淋巴结数量较少与复发和生存结局独立相关,而组织学低分化是SSO组的独立相关参数。晚期和神经周围侵犯在两组中均被确定为独立的预后参数。
本研究表明,APR的长期肿瘤学结局与SSO相当。由于与肿瘤学结局相关的预后参数在各自的手术中有所不同,可通过完整的直肠系膜全切除和个性化的全身治疗改善可纠正的参数。